The natural history of Crohn's disease in children: A review of population-based studies

European Journal of Gastroenterology and Hepatology

Volumn 29, Issue 2, 2017, Pages 125-134

  Duricova, Dana ^a,b,c   Fumery, Mathurin ^c   Annese, Vito ^g   Lakatos, Peter L ^h   Peyrin Biroulet, Laurent ^d   Gower Rousseau, Corinne ^c,e,f  

^a 1 LF UK   (Czech Republic)

^b CHARLES UNIVERSITY   (Czech Republic)

^c AMIENS UNIVERSITY HOSPITAL   (France)

^d INSERM   (France)

^e Centre Hospitalier Régional Universitaire   (France)

^f UNIVERSITÉ DE LILLE   (France)

^g CAREGGI UNIVERSITY HOSPITAL   (Italy)

^h SEMMELWEIS UNIVERSITY   (Hungary)

Author keywords

Crohn's disease; Epidemiology; Inflammatory bowel disease; Paediatrics

Indexed keywords

CORTICOSTEROID; IMMUNOSUPPRESSIVE AGENT; TUMOR NECROSIS FACTOR INHIBITOR; BIOLOGICAL PRODUCT; IMMUNOLOGIC FACTOR;

ANUS DISEASE; CANCER MORTALITY; CANCER RECURRENCE; COHORT ANALYSIS; CORTICOSTEROID THERAPY; CROHN DISEASE; DISEASE COURSE; EMBASE; ENTEROPATHY; HOSPITALIZATION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LONG TERM CARE; MEDLINE; NEOPLASM; PHENOTYPE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PUBERTY; PUBLICATION; REVIEW; ABDOMINAL SURGERY; ADOLESCENT; CHILD; INCIDENCE; MORTALITY; PATHOPHYSIOLOGY; RISK;

ADOLESCENT; ADRENAL CORTEX HORMONES; BIOLOGICAL PRODUCTS; CHILD; CROHN DISEASE; DIGESTIVE SYSTEM SURGICAL PROCEDURES; DISEASE PROGRESSION; HUMANS; IMMUNOLOGIC FACTORS; IMMUNOSUPPRESSIVE AGENTS; INCIDENCE; PHENOTYPE; RISK;

EID: 84991503741     PISSN: 0954691X     EISSN: 14735687     Source Type: Journal    
DOI: 10.1097/MEG.0000000000000761     Document Type: Review

References (70)

1. Benchimol EI, Fortinsky KJ, Gozdyra P, van den Heuvel M, van Limbergen J, Griffiths AM. Epidemiology of pediatric inflammatory bowel disease: a systematic review of international trends. Inflamm Bowel Dis 2011;17:423-439.
2. Duricova D, Burisch J, Jess T, Gower-Rousseau C, Lakatos PL. ECCOEpiCom. Age-related differences in presentation and course of inflammatory bowel disease: an update on the population-based literature. J Crohns Colitis 2014;8:1351-1361.
3. Lakatos PL, Golovics PA, David G, Pandur T, Erdelyi Z, Horvath A, et al. Has there been a change in the natural history of Crohn's disease? Surgical rates and medical management in a population-based inception cohort from Western Hungary between 1977-2009. Am J Gastroenterol 2012;107:579-588.
4. Ramadas AV, Gunesh S, Thomas GA, Williams GT, Hawthorne AB. Natural history of Crohn's disease in a population-based cohort from Cardiff (1986-2003): a study of changes in medical treatment and surgical resection rates. Gut 2010;59:1200-1206.
5. Satsangi J, Silverberg MS, Vermeire S, Colombel JF. The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications. Gut 2006;55:749-753.
6. Levine A, Griffiths A, Markowitz J, Wilson DC, Turner D, Russell RK, et al. Pediatric modification of the Montreal classification for inflammatory bowel disease: the Paris classification. Inflamm Bowel Dis 2011;17:1314-1321.
7. Langholz E, Munkholm P, Krasilnikoff PA, Binder V. Inflammatory bowel diseases with onset in childhood. Clinical features, morbidity, and mortality in a regional cohort. Scand J Gastroenterol 1997;32:139-147.
8. Jakobsen C, Paerregaard A, Munkholm P, Wewer V. Paediatric inflammatory bowel disease during a 44-year period in Copenhagen County: occurrence, course and prognosis - a population-based study from the Danish Crohn Colitis Database. Eur J Gastroenterol Hepatol 2009;21:1291-1301.
9. Jakobsen C, Bartek J, Wewer V, Vind I, Munkholm P, Groen R, et al. Differences in phenotype and disease course in adult and paediatric inflammatory bowel disease - a population-based study. Aliment Pharmacol Ther 2011;34:1217-1224.
10. Jakobsen C, Munkholm P, Paerregaard A, Wewer V. Steroid dependency and pediatric inflammatory bowel disease in the era of immunomodulators - a population-based study. Inflamm Bowel Dis 2011;17:1731-1740.
11. Jakobsen C, Paerregaard A, Munkholm P, Faerk J, Lange A, Andersen J, et al. Pediatric inflammatory bowel disease: increasing incidence, decreasing surgery rate, and compromised nutritional status: a prospective population-based cohort study 2007-2009. Inflamm Bowel Dis 2011;17:2541-2550.
12. Paerregaard A, Uldall Urne F. Anthropometry at the time of diagnosis in Danish children with inflammatory bowel disease. Acta Paediatr 2005;94:1682-1683.
13. Wewer V, Riis L, Vind I, Husby S, Munkholm P, Paerregaard A. Infliximab dependency in a national cohort of children with Crohn's disease. J Pediatr Gastroenterol Nutr 2006;42:40-45.
14. Vernier-Massouille G, Balde M, Salleron J, Turck D, Dupas JL, Mouterde O, et al. Natural history of pediatric Crohn's disease: a population-based cohort study. Gastroenterology 2008;135:1106-1113.
15. Vasseur F, Gower-Rousseau C, Vernier-Massouille G, Dupas JL, Merle V, Merlin B, et al. Nutritional status and growth in pediatric Crohn's disease: a population-based study. Am J Gastroenterol 2010;105:1893-1900.
16. Boualit M, Salleron J, Turck D, Fumery M, Savoye G, Dupas JL, et al. Long-term outcome after first intestinal resection in pediatric-onset Crohn's disease: a population-based study. Inflamm Bowel Dis 2013;19:7-14.
17. Crombé V, Salleron J, Savoye G, Dupas JL, Vernier-Massouille G, Lerebours E, et al. Long-term outcome of treatment with infliximab in pediatric-onset Crohn's disease: a population-based study. Inflamm Bowel Dis 2011;17:2144-2152.
18. Peneau A, Savoye G, Turck D, Dauchet L, Fumery M, Salleron J, et al. Mortality and cancer in pediatric-onset inflammatory bowel disease: a population-based study. Am J Gastroenterol 2013;108:1647-1653.
19. Tourtelier Y, Dabadie A, Tron I, Alexandre JL, Robaskiewicz M, Cruchant E, et al. Incidence of inflammatory bowel disease in children in Brittany (1994-1997). Breton association of study and research on digestive system diseases (Abermad). Arch Pediatr 2000;7:377-384.
20. Stordal K, Jahnsen J, Bentsen BS, Moum B. Pediatric inflammatory bowel disease in southeastern Norway: a five-year follow-up study. Digestion 2004;70:226-230.
21. Perminow G, Frigessi A, Rydning A, Nakstad B, Vatn MH. Incidence and clinical presentation of IBD in children: comparison between prospective and retrospective data in a selected Norwegian population. Scand J Gastroenterol 2006;41:1433-1439.
22. Perminow G, Brackmann S, Lyckander LG, Franke A, Borthne A, Rydning A, et al. A characterization in childhood inflammatory bowel disease, a new population-based inception cohort from South-Eastern Norway, 2005-2007, showing increased incidence in Crohn's disease. Scand J Gastroenterol 2009;44:446-456.
23. Olbjorn C, Nakstad B, Smastuen MC, Thiis-Evensen E, Vatn MH, Perminow G. Early anti-TNF treatment in pediatric Crohn's disease. Predictors of clinical outcome in a population-based cohort of newly diagnosed patients. Scand J Gastroenterol 2014;49:1425-1431.
24. Olafsdottir EJ, Fluge G, Haug K. Chronic inflammatory bowel disease in children in western Norway. J Pediatr Gastroenterol Nutr 1989;8:454-458.
25. Malmborg P, Grahnquist L, Ideström M, Lindholm J, Befrits R, Björk J, et al. Presentation and progression of childhood-onset inflammatory bowel disease in Northern Stockholm County. Inflamm Bowel Dis 2015;21:1098-1108.
26. Hildebrand H, Karlberg J, Kristiansson B. Longitudinal growth in children and adolescents with inflammatory bowel disease. J Pediatr Gastroenterol Nutr 1994;18:165-173.
27. Lindquist BL, Järnerot G, Wickbom G. Clinical and epidemiological aspects of Crohn's disease in children and adolescents. Scand J Gastroenterol 1984;19:502-506.
28. Lindberg E, Lindquist B, Holmquist L, Hildebrand H. Inflammatory bowel disease in children and adolescents in Sweden, 1984-1995. J Pediatr Gastroenterol Nutr 2000;30:259-264.
29. Turunen P, Ashorn M, Auvinen A, Iltanen S, Huhtala H, Kolho KL. Longterm health outcomes in pediatric inflammatory bowel disease: a population-based study. Inflamm Bowel Dis 2009;15:56-62.
30. Turunen P, Kolho KL, Auvinen A, Iltanen S, Huhtala H, Ashorn M. Incidence of inflammatory bowel disease in Finnish children, 1987-2003. Inflamm Bowel Dis 2006;12:677-683.
31. Agnarsson U, Björnsson S, Jóhansson JH, Sigurdsson L. Inflammatory bowel disease in Icelandic children 1951-2010. Population-based study involving one nation over six decades. Scand J Gastroenterol 2013;48:1399-1404.
32. Lovasz BD, Lakatos L, Horvath A, Pandur T, Erdelyi Z, Balogh M, et al. Incidence rates and disease course of paediatric inflammatory bowel diseases in Western Hungary between 1977 and 2011. Dig Liver Dis 2014;46:405-411.
33. Castro M, Papadatou B, Baldassare M, Balli F, Barabino A, Barbera C, et al. Inflammatory bowel disease in children and adolescents in Italy: data from the pediatric national IBD register (1996-2003). Inflamm Bowel Dis 2008;14:1246-1252.
34. Orel R, Kamhi T, Vidmar G, Mamula P. Epidemiology of pediatric chronic inflammatory bowel disease in central and western Slovenia, 1994-2005. J Pediatr Gastroenterol Nutr 2009;48:579-586.
35. Urlep D, Trop TK, Blagus R, Orel R. Incidence and phenotypic characteristics of pediatric IBD in northeastern Slovenia, 2002-2010. J Pediatr Gastroenterol Nutr 2014;58:325-332.
36. de Ridder L, Rings EH, Damen GM, Kneepkens CM, Schweizer JJ, Kokke FT, et al. Infliximab dependency in pediatric Crohn's disease: long-term follow-up of an unselected cohort. Inflamm Bowel Dis 2008;14:353-358.
37. Burisch J, Pedersen N, Èukoviæ-Èavka S, Brinar M, Kaimakliotis I, Duricova D, et al. East-West gradient in the incidence of inflammatory bowel disease in Europe: the ECCO-EpiCom inception cohort. Gut 2014;63:588-597.
38. Sawczenko A, Sandhu BK. Presenting features of inflammatory bowel disease in Great Britain and Ireland. Arch Dis Child 2003;88:995-1000.
39. Hope B, Shahdadpuri R, Dunne C, Broderick AM, Grant T, Hamzawi M, et al. Rapid rise in incidence of Irish paediatric inflammatory bowel disease. Arch Dis Child 2012;97:590-594.
40. Hassan K, Cowan FJ, Jenkins HR. The incidence of childhood inflammatory bowel disease in Wales. Eur J Pediatr 2000;159:261-263.
41. Van Limbergen J, Russell RK, Drummond HE, Aldhous MC, Round NK, Nimmo ER, et al. Definition of phenotypic characteristics of childhoodonset inflammatory bowel disease. Gastroenterology 2008;135:1114-1122.
42. Barton JR, Ferguson A. Clinical features, morbidity and mortality of Scottish children with inflammatory bowel disease. Q J Med 1990;75:423-439.
43. Ferguson A, Sedgwick DM. Juvenile onset inflammatory bowel disease: height and body mass index in adult life. BMJ 1994;308:1259-1263.
44. Sedgwick DM, Barton JR, Hamer-Hodges DW, Nixon SJ, Ferguson A. Population-based study of surgery in juvenile onset Crohn's disease. Br J Surg 1991;78:171-175.
45. Tung J, Loftus EV, Freese DK, El-Youssef M, Zinsmeister AR, Melton LJ, et al. A population-based study of the frequency of corticosteroid resistance and dependence in pediatric patients with Crohn's disease and ulcerative colitis. Inflamm Bowel Dis 2006;12:1093-1100.
46. Kugathasan S, Judd RH, Hoffmann RG, Heikenen J, Telega G, Khan F, et al. Epidemiologic and clinical characteristics of children with newly diagnosed inflammatory bowel disease in Wisconsin: a statewide population-based study. J Pediatr 2003;143:525-531.
47. Adamiak T, Walkiewicz-Jedrzejczak D, Fish D, Brown C, Tung J, Khan K, et al. Incidence, clinical characteristics, and natural history of pediatric IBD in Wisconsin: a population-based epidemiological study. Inflamm Bowel Dis 2013;19:1218-1223.
48. Debruyn JC, Soon IS, Hubbard J, Wrobel I, Panaccione R, Kaplan GG. Nationwide temporal trends in incidence of hospitalization and surgical intestinal resection in pediatric inflammatory bowel diseases in the United States from 1997 to 2009. Inflamm Bowel Dis 2013;19:2423-2432.
49. Benchimol EI, Guttmann A, To T, Rabeneck L, Griffiths AM. Changes to surgical and hospitalization rates of pediatric inflammatory bowel disease in Ontario, Canada (1994-2007). Inflamm Bowel Dis 2011;17:2153-2161.
50. Benchimol EI, Mack DR, Nguyen GC, Snapper SB, Li W, Mojaverian N, et al. Incidence, outcomes, and health services burden of very early onset inflammatory bowel disease. Gastroenterology 2014;147:803.e7-813.e7. quiz e14-e15.
51. Singh H, Nugent Z, Targownik LE, El-Matary W, Brownell M, Bernstein CN. Health care use by a population-based cohort of children with inflammatory bowel disease. Clin Gastroenterol Hepatol 2015;137:1302.e3-1309.e3.
52. Carroll MW, Hamilton Z, Gill H, Simkin J, Smyth M, Espinosa V, et al. Pediatric inflammatory bowel disease among South Asians living in British Columbia, Canada: a distinct clinical phenotype. Inflamm Bowel Dis 2016;22:387-396.
53. Phavichitr N, Cameron DJ, Catto-Smith AG. Increasing incidence of Crohn's disease in Victorian children. J Gastroenterol Hepatol 2003;18:329-332.
54. Yap J, Wesley A, Mouat S, Chin S. Paediatric inflammatory bowel disease in New Zealand. N Z Med J 2008;121:19-34.
55. Tarrant KM, Barclay ML, Frampton CM, Gearry RB. Perianal disease predicts changes in Crohn's disease phenotype-results of a populationbased study of inflammatory bowel disease phenotype. Am J Gastroenterol 2008;103:3082-3093.
56. Vind I, Riis L, Jess T, Knudsen E, Pedersen N, Elkjaer M, et al. Increasing incidences of inflammatory bowel disease and decreasing surgery rates in Copenhagen City and County, 2003-2005: a population-based study from the Danish Crohn colitis database. Am J Gastroenterol 2006;101:1274-1282.
57. Thia KT, Sandborn WJ, Harmsen WS, Zinsmeister AR, Loftus EV. Risk factors associated with progression to intestinal complications of Crohn's disease in a population-based cohort. Gastroenterology 2010;139:1147-1155.
58. Tang LY, Rawsthorne P, Bernstein CN. Are perineal and luminal fistulas associated in Crohn's disease? A population-based study. Clin Gastroenterol Hepatol 2006;4:1130-1134.
59. Eglinton T, Reilly M, Chang C, Barclay M, Frizelle F, Gearry R. Ileal disease is associated with surgery for perianal disease in a populationbased Crohn's disease cohort. Br J Surg 2010;97:1103-1109.
60. Jess T, Winther KV, Munkholm P, Langholz E, Binder V. Mortality and causes of death in Crohn's disease: follow-up of a population-based cohort in Copenhagen County, Denmark. Gastroenterology 2002;122:1808-1814.
61. Jess T, Loftus EV, Harmsen WS, Zinsmeister AR, Tremaine WJ, Melton LJ, et al. Survival and cause specific mortality in patients with inflammatory bowel disease: a long term outcome study in Olmsted County, Minnesota, 1940-2004. Gut 2006;55:1248-1254.
62. Jess T, Simonsen J, Jørgensen KT, Pedersen BV, Nielsen NM, Frisch M. Decreasing risk of colorectal cancer in patients with inflammatory bowel disease over 30 years. Gastroenterology 2012;143:375.e1-381.e1. quiz e13-e14.
63. Jess T, Horváth-Puhó E, Fallingborg J, Rasmussen HH, Jacobsen BA. Cancer risk in inflammatory bowel disease according to patient phenotype and treatment: a Danish population-based cohort study. Am J Gastroenterol 2013;108:1869-1876.
64. Jess T, Frisch M, Simonsen J. Trends in overall and cause-specific mortality among patients with inflammatory bowel disease from 1982 to 2010. Clin Gastroenterol Hepatol 2013;11:43-48.
65. Canavan C, Abrams KR, Hawthorne B, Mayberry JF. Long-term prognosis in Crohn's disease: an epidemiological study of patients diagnosed more than 20 years ago in Cardiff. Aliment Pharmacol Ther 2007;25:59-65.
66. Probert CS, Jayanthi V, Wicks AC, Mayberry JF. Mortality from Crohn's disease in Leicestershire, 1972-1989: an epidemiological community based study. Gut 1992;33:1226-1228.
67. Sjöberg D, Holmström T, Larsson M, Nielsen AL, Holmquist L, Ekbom A, et al. Incidence and clinical course of Crohn's disease during the first year - results from the IBD Cohort of the Uppsala Region (ICURE) of Sweden 2005-2009. J Crohns Colitis 2014;8:215-222.
68. Bitton A, Vutcovici M, Sewitch M, Suissa S, Brassard P. Mortality trends in Crohn's disease and ulcerative colitis: a population-based study in Québec, Canada. Inflamm Bowel Dis 2016;22:416-423.
69. Shapiro JM, Hagin SE, Shah SA, Bright R, Law M, Moniz H, et al. Corticosteroid use in a prospective, community-based cohort of newly diagnosed inflammatory bowel disease patients. Dig Dis Sci 2016;61:1635-1640.
70. Cameron FL, Wilson ML, Basheer N, Jamison A, McGrogan P, Bisset WM, et al. Anti-TNF therapy for paediatric IBD: the Scottish national experience. Arch Dis Child 2015;100:399-405.